Monkey Pox: Is it a Pandemic? Dr. Blaylock Reports

SUMMARY:  Dr. Russell Blaylock continues his Healthy Longevity and Blaylock Reports series with an analysis of the Mpox also known as Monkey Pox infection that started in the Democratic Republic of the Congo in SubSaharan Africa. "Because the name  (Monkey Pox) reinforced racism and stigma about African countries being the source of the Disease"- (Similar to The China Virus for Covid 19),...the name was changed to Mpox. "Several public health organizations and scientists argued that the former geographical names were hindering efforts to contain the disease" (Wikipedia) Unfortunately that name change  misses the main causes of the disease from sexual contact with persons having the skin infected with virus, and inadequate immune responses related to malnutrition. Thus, the disease is not a pandemic as it is not world wide because those conditions do not exist everywhere. It is endemic to part of Africa. (Another example of Political Correctness corrupting science.)  The disease is similar to Small Pox with skin rash and blistering from skin contact with infected individuals accompanied by  myalgia and fatigue. Some more severe complications can occur with secondary infections in immuno-compromised people. There is no vaccine, and no treatment except symptomatic care. It is from a double stranded DNA virus. The virus can be transmitted among humans mostly by sexual intercourse or touching of infected people. It is mostly confined to Central and Western Africa. Again, the disease is used to alarm the public forcing them to adopt the procedures of the WHO, which has other motives to subjugate the populations to its regulations.  This is another corruption of healthcare  for political reasons.  This information is not commonly found in the Media.  This  program is available under  "SNI Digital" on Amazon, Spotify and Apple Podcasts.  24 minutes. (JIA)

Speaker
  • James I. Ausman, MD, MA, PhD

    CEO SNI and SNI Digital; Emeritus Professor Neurosurgery

  • Russell Blaylock, MD

    CEO, Theoretical Neuroscience Research